Kalistan sees opportunity beyond its shores
Inks major deal with KeymonKaliburg, Ananto
June 15, 4445Trade Minister Bill Sykes, center, scores another victory for diversification as two major deals are quickly concluded with KeymonBuilding on the ODEN Partnership between Kalistan and Keymon, Trade and Industry Minister Bill Sykes announced that two major deals have been concluded with the Mad Dog Republic.
Minister Sykes was on hand to announce the preliminary deals.
"It seems like an age ago when Kalistani investors were panicking, and Kalistani bank customers were scrambling for Rubles from the Bank. And now, all of that is in the past. Through hard work, solid reassessment of our economic and fiscal priorities and a whole lot of luck, Kalistan has emerged from the dark time of Monetary crisis into the bright sunshine of economic expansion. The deals we will soon conclude with Keymon will see KalMD open a new Branch in Keymon, to make phones specifically for the Keymonese Market.
"KalMD's expansion there will be fully funded by new capital recruitment, both in Kalistan and in Keymon. KalMD will experiment with a new type of corporate structure for their overseas expansion: While this company will be entirely opened to foreign investment, with KalMD retaining 50.1% of the stock interest, Kalistan will send technical expertise in manufacturing our products and overseeing QC, but the expansion plant will be fully staffed by Keymonese managers and workers. They will set pay and work conditions, while KalMD supplies the technical expertise, and export the semi-finished materials to Keymon. If Keymon's demand for cellular phones is met by KalMD's production in Kalistan, the surplus will be exported abroad, with all profits returning to research and development, after the dividend is paid out.
"In addition to the KalMD expansion, ODEN's fully owned Pharmaceuticals conglomerate, led by Supereon Pharmaceuticals and Valutrex Pharma will officially merge with Keymon Pharmaceuticals. The new conglomerate will be fully free to merge all intellectual property and will work on cornering the therapeutic pharmaceuticals market in the world. The Multinational conglomerate will be overseen by Boards appointed by ODEN in our respective countries, and will open the door for large scale Kaymonese investment in the Kalistani Market.
"It is estimated that these deals will be worth tens of billions of Rubles to each Partner, clear, in a year. And with such a large scale expansion of KalMD and the merger of the Kalistani and Keymon Pharmaceutical industries, production will begin ramping up sooner rather than later."
News of the new deal sent KalMD stocks on an upward trajectory, as KMD gained 14 points on the day and KalMM, which stands to benefit from the expansion, was up 7 points on the day. Meanwhile, the Kalsie index overall was up 8/10ths of a percent. 4445 is turning into a remarkable year as Kalistan begins to erase the losses of the recession.